Shc isoform-specific tyrosine phosphorylation by the insulin and epidermal growth factor receptors

S. Okada, K. Yamauchi, Jeffrey E. Pessin

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Insulin stimulation of Chinese hamster ovary cells expressing the human insulin and epidermal growth factor (EGF) receptors (CHO/IR/ER) resulted in the tyrosine phosphorylation of the 52-kDa Shc isoform with a relatively low extent of 46-kDa Shc tyrosine phosphorylation. In contrast, EGF stimulation resulted in the tyrosine phosphorylation of both the 52- and 46-kDa Shc isoforms. Consistent with these differences, Grb2 predominantly bound to the 52-kDa Shc isoform following insulin stimulation, whereas Grb2 associated with both the 52- and 46-kDa Shc isoforms after EGF stimulation. Further, in vitro kinetic analysis demonstrated that the insulin receptor has a 4-fold greater V(max) with no significant difference in the K(m) for the purified 52-kDa Shc isoform compared with the 46-kDa Shc isoform. However, the EGF receptor displayed the identical V(max) and K(m) for tyrosine phosphorylation of both of these species. In direct contrast to the EGF receptor, we also observed significant differences in binding interactions between the insulin receptor with the 52- and 46-kDa Shc isoforms in vitro. These data demonstrate that the predominant insulin-dependent Shc signaling pathway occurs via the 52-kDa Shc isoform, whereas the EGF receptor can effectively use both the 52- and 46-kDa Shc species.

Original languageEnglish (US)
Pages (from-to)20737-20741
Number of pages5
JournalJournal of Biological Chemistry
Volume270
Issue number35
DOIs
StatePublished - 1995
Externally publishedYes

Fingerprint

Phosphorylation
Tyrosine
Protein Isoforms
Insulin
Epidermal Growth Factor Receptor
Insulin Receptor
Epidermal Growth Factor
ErbB Receptors
Cricetulus
Ovary
Cells
Kinetics

ASJC Scopus subject areas

  • Biochemistry

Cite this

Shc isoform-specific tyrosine phosphorylation by the insulin and epidermal growth factor receptors. / Okada, S.; Yamauchi, K.; Pessin, Jeffrey E.

In: Journal of Biological Chemistry, Vol. 270, No. 35, 1995, p. 20737-20741.

Research output: Contribution to journalArticle

@article{3854b2a84db54a2f925d8010c02e3256,
title = "Shc isoform-specific tyrosine phosphorylation by the insulin and epidermal growth factor receptors",
abstract = "Insulin stimulation of Chinese hamster ovary cells expressing the human insulin and epidermal growth factor (EGF) receptors (CHO/IR/ER) resulted in the tyrosine phosphorylation of the 52-kDa Shc isoform with a relatively low extent of 46-kDa Shc tyrosine phosphorylation. In contrast, EGF stimulation resulted in the tyrosine phosphorylation of both the 52- and 46-kDa Shc isoforms. Consistent with these differences, Grb2 predominantly bound to the 52-kDa Shc isoform following insulin stimulation, whereas Grb2 associated with both the 52- and 46-kDa Shc isoforms after EGF stimulation. Further, in vitro kinetic analysis demonstrated that the insulin receptor has a 4-fold greater V(max) with no significant difference in the K(m) for the purified 52-kDa Shc isoform compared with the 46-kDa Shc isoform. However, the EGF receptor displayed the identical V(max) and K(m) for tyrosine phosphorylation of both of these species. In direct contrast to the EGF receptor, we also observed significant differences in binding interactions between the insulin receptor with the 52- and 46-kDa Shc isoforms in vitro. These data demonstrate that the predominant insulin-dependent Shc signaling pathway occurs via the 52-kDa Shc isoform, whereas the EGF receptor can effectively use both the 52- and 46-kDa Shc species.",
author = "S. Okada and K. Yamauchi and Pessin, {Jeffrey E.}",
year = "1995",
doi = "10.1074/jbc.270.35.20737",
language = "English (US)",
volume = "270",
pages = "20737--20741",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "35",

}

TY - JOUR

T1 - Shc isoform-specific tyrosine phosphorylation by the insulin and epidermal growth factor receptors

AU - Okada, S.

AU - Yamauchi, K.

AU - Pessin, Jeffrey E.

PY - 1995

Y1 - 1995

N2 - Insulin stimulation of Chinese hamster ovary cells expressing the human insulin and epidermal growth factor (EGF) receptors (CHO/IR/ER) resulted in the tyrosine phosphorylation of the 52-kDa Shc isoform with a relatively low extent of 46-kDa Shc tyrosine phosphorylation. In contrast, EGF stimulation resulted in the tyrosine phosphorylation of both the 52- and 46-kDa Shc isoforms. Consistent with these differences, Grb2 predominantly bound to the 52-kDa Shc isoform following insulin stimulation, whereas Grb2 associated with both the 52- and 46-kDa Shc isoforms after EGF stimulation. Further, in vitro kinetic analysis demonstrated that the insulin receptor has a 4-fold greater V(max) with no significant difference in the K(m) for the purified 52-kDa Shc isoform compared with the 46-kDa Shc isoform. However, the EGF receptor displayed the identical V(max) and K(m) for tyrosine phosphorylation of both of these species. In direct contrast to the EGF receptor, we also observed significant differences in binding interactions between the insulin receptor with the 52- and 46-kDa Shc isoforms in vitro. These data demonstrate that the predominant insulin-dependent Shc signaling pathway occurs via the 52-kDa Shc isoform, whereas the EGF receptor can effectively use both the 52- and 46-kDa Shc species.

AB - Insulin stimulation of Chinese hamster ovary cells expressing the human insulin and epidermal growth factor (EGF) receptors (CHO/IR/ER) resulted in the tyrosine phosphorylation of the 52-kDa Shc isoform with a relatively low extent of 46-kDa Shc tyrosine phosphorylation. In contrast, EGF stimulation resulted in the tyrosine phosphorylation of both the 52- and 46-kDa Shc isoforms. Consistent with these differences, Grb2 predominantly bound to the 52-kDa Shc isoform following insulin stimulation, whereas Grb2 associated with both the 52- and 46-kDa Shc isoforms after EGF stimulation. Further, in vitro kinetic analysis demonstrated that the insulin receptor has a 4-fold greater V(max) with no significant difference in the K(m) for the purified 52-kDa Shc isoform compared with the 46-kDa Shc isoform. However, the EGF receptor displayed the identical V(max) and K(m) for tyrosine phosphorylation of both of these species. In direct contrast to the EGF receptor, we also observed significant differences in binding interactions between the insulin receptor with the 52- and 46-kDa Shc isoforms in vitro. These data demonstrate that the predominant insulin-dependent Shc signaling pathway occurs via the 52-kDa Shc isoform, whereas the EGF receptor can effectively use both the 52- and 46-kDa Shc species.

UR - http://www.scopus.com/inward/record.url?scp=0029130717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029130717&partnerID=8YFLogxK

U2 - 10.1074/jbc.270.35.20737

DO - 10.1074/jbc.270.35.20737

M3 - Article

VL - 270

SP - 20737

EP - 20741

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 35

ER -